Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Aspen Pharmacare, a leading global player in the research and development services sector, is headquartered in South Africa (ZA). Founded in 1850, the company has established a strong presence across various regions, including Europe, Asia, and Latin America. Specialising in the development and manufacturing of high-quality pharmaceuticals, Aspen focuses on key therapeutic areas such as anaesthesia, oncology, and thrombosis.
With a commitment to innovation, Aspen Pharmacare has achieved significant milestones, including the expansion of its product portfolio and strategic acquisitions that enhance its market position. The company is renowned for its unique approach to generic and branded medicines, ensuring accessibility and affordability for patients worldwide. Aspen's dedication to quality and sustainability has solidified its reputation as a trusted partner in the global healthcare landscape.
+13 vs industry average
Aspen Pharmacare’s score of 46 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research Services has below-average carbon intensity
The Research Services industry has reduced its overall emissions by 19% since 2018
Scope 3 accounts for ••• of total emissions.
Aspen Pharmacare's most recent disclosed emissions data for 2025 indicates Scope 1 emissions of 32,776,000 kg CO2e and Scope 2 emissions of 115,505,000 kg CO2e. The company has not disclosed Scope 3 emissions for this period.
Aspen Pharmacare is committed to significant climate action, with several reduction targets:
Historically, Aspen Pharmacare has achieved notable reductions, with Scope 1 emissions decreasing by 64% from 18,896,000 kg CO2e in 2012 to 6,774,000 kg CO2e in 2013, and Scope 2 emissions decreasing by 44% from 158,035,000 kg CO2e to 88,008,000 kg CO2e during the same period.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more